Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
Accurate prognostic information is desirable when counselling patients with brain metastases regarding their therapeutic options and life expectancy. Based on previous studies, we selected serum lactate dehydrogenase (LDH) as a promising factor on which we perform a pilot study investigating methodo...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/2012/609323 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524440038375424 |
|---|---|
| author | Carsten Nieder Kirsten Marienhagen Astrid Dalhaug Jan Norum |
| author_facet | Carsten Nieder Kirsten Marienhagen Astrid Dalhaug Jan Norum |
| author_sort | Carsten Nieder |
| collection | DOAJ |
| description | Accurate prognostic information is desirable when counselling patients with brain metastases regarding their therapeutic options and life expectancy. Based on previous studies, we selected serum lactate dehydrogenase (LDH) as a promising factor on which we perform a pilot study investigating methodological aspects of biomarker studies in patients with brain metastases, before embarking on large-scale studies that will look at a larger number of candidate markers in an expanded patient cohort. For this retrospective analysis, 100 patients with available information on LDH treated with palliative whole-brain radiotherapy were selected. A comprehensive evaluation of different LDH-based variables was performed in uni- and multivariate tests. Probably, the most intriguing finding was that LDH kinetics might be more important, or at least complement, information obtained from a single measurement immediately before radiotherapy. LDH and performance status outperformed several other variables that are part of prognostic models such as recursive partitioning analyses classes and graded prognostic assessment score. LDH kinetics might reflect disease behaviour in extracranial metastatic and primary sites without need for comprehensive imaging studies and is a quite inexpensive diagnostic test. Based on these encouraging results, confirmatory studies in a larger cohort of patients are warranted. |
| format | Article |
| id | doaj-art-22f92f9d8e3643bead45ca217e840c7c |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-22f92f9d8e3643bead45ca217e840c7c2025-02-03T05:53:07ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/609323609323Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase LevelsCarsten Nieder0Kirsten Marienhagen1Astrid Dalhaug2Jan Norum3Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, NorwayDepartment of Oncology, University Hospital of Northern Norway, 9038 Tromsø, NorwayDepartment of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, NorwayInstitute of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037 Tromsø, NorwayAccurate prognostic information is desirable when counselling patients with brain metastases regarding their therapeutic options and life expectancy. Based on previous studies, we selected serum lactate dehydrogenase (LDH) as a promising factor on which we perform a pilot study investigating methodological aspects of biomarker studies in patients with brain metastases, before embarking on large-scale studies that will look at a larger number of candidate markers in an expanded patient cohort. For this retrospective analysis, 100 patients with available information on LDH treated with palliative whole-brain radiotherapy were selected. A comprehensive evaluation of different LDH-based variables was performed in uni- and multivariate tests. Probably, the most intriguing finding was that LDH kinetics might be more important, or at least complement, information obtained from a single measurement immediately before radiotherapy. LDH and performance status outperformed several other variables that are part of prognostic models such as recursive partitioning analyses classes and graded prognostic assessment score. LDH kinetics might reflect disease behaviour in extracranial metastatic and primary sites without need for comprehensive imaging studies and is a quite inexpensive diagnostic test. Based on these encouraging results, confirmatory studies in a larger cohort of patients are warranted.http://dx.doi.org/10.1100/2012/609323 |
| spellingShingle | Carsten Nieder Kirsten Marienhagen Astrid Dalhaug Jan Norum Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels The Scientific World Journal |
| title | Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels |
| title_full | Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels |
| title_fullStr | Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels |
| title_full_unstemmed | Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels |
| title_short | Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels |
| title_sort | towards improved prognostic scores predicting survival in patients with brain metastases a pilot study of serum lactate dehydrogenase levels |
| url | http://dx.doi.org/10.1100/2012/609323 |
| work_keys_str_mv | AT carstennieder towardsimprovedprognosticscorespredictingsurvivalinpatientswithbrainmetastasesapilotstudyofserumlactatedehydrogenaselevels AT kirstenmarienhagen towardsimprovedprognosticscorespredictingsurvivalinpatientswithbrainmetastasesapilotstudyofserumlactatedehydrogenaselevels AT astriddalhaug towardsimprovedprognosticscorespredictingsurvivalinpatientswithbrainmetastasesapilotstudyofserumlactatedehydrogenaselevels AT jannorum towardsimprovedprognosticscorespredictingsurvivalinpatientswithbrainmetastasesapilotstudyofserumlactatedehydrogenaselevels |